430 related articles for article (PubMed ID: 33013745)
1. Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay.
Almahboub SA; Algaissi A; Alfaleh MA; ElAssouli MZ; Hashem AM
Front Microbiol; 2020; 11():2020. PubMed ID: 33013745
[TBL] [Abstract][Full Text] [Related]
2. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
[TBL] [Abstract][Full Text] [Related]
3. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies.
Lester S; Harcourt J; Whitt M; Al-Abdely HM; Midgley CM; Alkhamis AM; Aziz Jokhdar HA; Assiri AM; Tamin A; Thornburg N
Access Microbiol; 2019; 1(9):e000057. PubMed ID: 32974558
[TBL] [Abstract][Full Text] [Related]
4. A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields.
Fujioka Y; Kashiwagi S; Yoshida A; Satoh AO; Fujioka M; Amano M; Yamauchi Y; Ohba Y
Cell Struct Funct; 2022 Jun; 47(1):43-53. PubMed ID: 35491102
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
6. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Xiong HL; Wu YT; Cao JL; Yang R; Liu YX; Ma J; Qiao XY; Yao XY; Zhang BH; Zhang YL; Hou WH; Shi Y; Xu JJ; Zhang L; Wang SJ; Fu BR; Yang T; Ge SX; Zhang J; Yuan Q; Huang BY; Li ZY; Zhang TY; Xia NS
Emerg Microbes Infect; 2020 Dec; 9(1):2105-2113. PubMed ID: 32893735
[TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
Nie J; Li Q; Wu J; Zhao C; Hao H; Liu H; Zhang L; Nie L; Qin H; Wang M; Lu Q; Li X; Sun Q; Liu J; Fan C; Huang W; Xu M; Wang Y
Emerg Microbes Infect; 2020 Dec; 9(1):680-686. PubMed ID: 32207377
[TBL] [Abstract][Full Text] [Related]
8. Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019.
Salazar-García M; Acosta-Contreras S; Rodríguez-Martínez G; Cruz-Rangel A; Flores-Alanis A; Patiño-López G; Luna-Pineda VM
Front Microbiol; 2021; 12():817200. PubMed ID: 35095820
[TBL] [Abstract][Full Text] [Related]
9. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD.
Septisetyani EP; Prasetyaningrum PW; Anam K; Santoso A
Immune Netw; 2021 Dec; 21(6):e39. PubMed ID: 35036026
[TBL] [Abstract][Full Text] [Related]
11. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
Joseph J; Karthika T; Das VRA; Raj VS
Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
[TBL] [Abstract][Full Text] [Related]
12. A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept.
Cruz-Cardenas JA; Gutierrez M; López-Arredondo A; Castañeda-Delgado JE; Rojas-Martinez A; Nakamura Y; Enciso-Moreno JA; Palomares LA; Brunck MEG
Sci Rep; 2022 Oct; 12(1):17966. PubMed ID: 36289285
[TBL] [Abstract][Full Text] [Related]
13. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
14. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
Oguntuyo KY; Stevens CS; Hung CT; Ikegame S; Acklin JA; Kowdle SS; Carmichael JC; Chiu HP; Azarm KD; Haas GD; Amanat F; Klingler J; Baine I; Arinsburg S; Bandres JC; Siddiquey MNA; Schilke RM; Woolard MD; Zhang H; ; Duty AJ; Kraus TA; Moran TM; Tortorella D; Lim JK; Gamarnik AV; Hioe CE; Zolla-Pazner S; Ivanov SS; Kamil JP; Krammer F; Lee B
mBio; 2021 Feb; 12(1):. PubMed ID: 33593976
[TBL] [Abstract][Full Text] [Related]
15. A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2-Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Cai Z; Kalkeri R; Zhu M; Cloney-Clark S; Haner B; Wang M; Osman B; Dent D; Feng SL; Longacre Z; Glenn G; Plested JS
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543552
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay.
D'Apice L; Trovato M; Gramigna G; Colavita F; Francalancia M; Matusali G; Meschi S; Lapa D; Bettini A; Mizzoni K; Aurisicchio L; Di Caro A; Castilletti C; De Berardinis P
Front Immunol; 2022; 13():981693. PubMed ID: 36225911
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
[TBL] [Abstract][Full Text] [Related]
18. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
[No Abstract] [Full Text] [Related]
19. Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses.
Neerukonda SN; Vassell R; Weiss CD; Wang W
Methods Mol Biol; 2022; 2452():305-314. PubMed ID: 35554914
[TBL] [Abstract][Full Text] [Related]
20. Presence of neutralizing SARS-CoV-2 antibodies in asymptomatic population of N'Djamena, Chad.
Wondeu ALD; Abakar MF; Frasca F; Nodjikouambaye AZ; Abdelrazakh F; Naibei N; Dzomo GRT; Djimtoibaye D; Mad-Toingue J; Scagnolari C; Antonelli G; Linardos G; Russo C; Perno CF; Yandai FH; Atturo S; Hiscott J; Colizzi V; Cappelli G; Ngueadoum N; Haroun A; Choua O; Moussa AM
Immun Inflamm Dis; 2024 Jan; 12(1):e1154. PubMed ID: 38270301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
